CRF-1 Antagonist and CRF-2 Agonist Decrease Binge-Like Ethanol Drinking in C57BL/6J Mice Independent of the HPA Axis
- 3 February 2010
- journal article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 35 (6) , 1241-1252
- https://doi.org/10.1038/npp.2009.209
Abstract
Recent evidence suggests that corticotropin-releasing factor (CRF) receptor (CRFR) signaling is involved in modulating binge-like ethanol consumption in C57BL/6J mice. In this report, a series of experiments were performed to further characterize the role of CRFR signaling in binge-like ethanol consumption. The role of central CRFR signaling was assessed with intracerebroventricular (i.c.v.) infusion of the nonselective CRFR antagonist, α-helical CRF9–41 (0, 1, 5, 10 μg/1 μl). The contribution of central CRF type 2 receptor (CRF2R) signaling was assessed with i.c.v. infusion of the selective CRF2R agonist, urocortin (Ucn) 3 (0, 0.05, 0.1, or 0.5 μg/1 μl). The role of the hypothalamic–pituitary–adrenal (HPA) axis was assessed by pretreating mice with intraperitoneal (i.p.) injection of (1) the corticosterone synthesis inhibitor, metyrapone (0, 50, 100, 150 mg/kg) or (2) the glucocorticoid receptor antagonist, mifepristone (0, 25, 50 mg/kg), and (3) by using radioimmunoassay to determine whether binge-like ethanol intake influenced plasma corticosterone levels. Finally, we determined whether the ability of the CRF1R antagonist, CP-154,526 (CP; 0, 10, 15 mg/kg, i.p.), to blunt binge-like drinking required normal HPA axis signaling by comparing the effectiveness of CP in adrenalectomized (ADX) and normal mice. Results showed that i.c.v. infusion of a 1 μg dose of α-helical CRF9–41 significantly attenuated binge-like ethanol consumption relative to vehicle treatment, and i.c.v. infusion of Ucn 3 dose-dependently blunted binge-like drinking. On the other hand, metyrapone nonselectively reduced both ethanol and sucrose consumption, mifepristone did not alter ethanol drinking, and binge-like drinking did not correlate with plasma corticosterone levels. Finally, i.p. injection of CP significantly attenuated binge-like ethanol intake in both ADX and normal mice. Together, these results suggest that binge-like ethanol intake in C57BL/6J mice is modulated by CRF1R and CRF2R signaling, such that blockade of CRF1R or activation of CRF2R effectively reduces excessive ethanol intake. Furthermore, normal HPA axis signaling is not necessary to achieve binge-like drinking behavior.Keywords
This publication has 108 references indexed in Scilit:
- Young Adult Smoking BehaviorAmerican Journal of Preventive Medicine, 2009
- Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J micePsychopharmacology, 2009
- Binge drinking in young adults: Data, definitions, and determinants.Psychological Bulletin, 2009
- Effects of the combination of metyrapone and oxazepam on cocaine and food self-administration in ratsPharmacology Biochemistry and Behavior, 2008
- Nonselective suppression of operant ethanol and sucrose self-administration by the mGluR7 positive allosteric modulator AMN082Pharmacology Biochemistry and Behavior, 2008
- Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1Journal of Biological Chemistry, 2008
- A Role for Brain Stress Systems in AddictionNeuron, 2008
- Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumptionNeuroscience, 2008
- Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States populationDrug and Alcohol Dependence, 2007
- A key role for corticotropin-releasing factor in alcohol dependenceTrends in Neurosciences, 2007